Onset Therapeutics is a pharmaceutical company, engaged in the development of topical products for the wound care markets. The company is a wholly-owned subsidiary of Collegium Pharmaceutical. The company`s products are used in the treatment of skin disorders, wounds, decubitus ulcers, varicose ulcers, dehiscent wounds, genital warts and venereal diseases. Its products are developed using its patented drug delivery formulations. Its emollient foam is used in treating xerosis, ichthyosis, skin cracks and fissures, dermatitis, eczema, psoriasis, keratoses and calluses. Onset`s products are used by dermatologists in long term care facilities, wound care clinics and hospitals. The company is headquartered in Rhode Island, the US.

On October 2, 2009, the company launched BenzEFoam Emollient Foam indicated for topical treatment of mild to moderate acne vulgaris.

Street: 
400 Highland Corporate Drive
City: 
Cumberland
Postcode: 
02864
Federal State : 
United States
WebSite: 
www.onsettx.com
Fax: 
1-401-7622043

Company Index Score

Current Index Score Historical Index Score
  • Onset Therapeutics LLC currently scores 50 % in the index.
  • Onset Therapeutics LLC is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Onset Therapeutics LLC is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets